COVID-19: Is there a role for immunonutrition in obese patient?

Abstract On December 12, 2019 a new coronavirus (SARS-CoV-2) emerged in Wuhan, China, triggering a pandemic of severe acute respiratory syndrome in humans (COVID-19). Today, the scientific community is investing all the resources available to find any therapy and prevention strategies to defeat COVI...

Full description

Bibliographic Details
Main Authors: Laura Di Renzo, Paola Gualtieri, Francesca Pivari, Laura Soldati, Alda Attinà, Claudia Leggeri, Giulia Cinelli, Maria Grazia Tarsitano, Giovanna Caparello, Elena Carrano, Giuseppe Merra, Alberto Maria Pujia, Roberta Danieli, Antonino De Lorenzo
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Journal of Translational Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12967-020-02594-4
_version_ 1828867848751022080
author Laura Di Renzo
Paola Gualtieri
Francesca Pivari
Laura Soldati
Alda Attinà
Claudia Leggeri
Giulia Cinelli
Maria Grazia Tarsitano
Giovanna Caparello
Elena Carrano
Giuseppe Merra
Alberto Maria Pujia
Roberta Danieli
Antonino De Lorenzo
author_facet Laura Di Renzo
Paola Gualtieri
Francesca Pivari
Laura Soldati
Alda Attinà
Claudia Leggeri
Giulia Cinelli
Maria Grazia Tarsitano
Giovanna Caparello
Elena Carrano
Giuseppe Merra
Alberto Maria Pujia
Roberta Danieli
Antonino De Lorenzo
author_sort Laura Di Renzo
collection DOAJ
description Abstract On December 12, 2019 a new coronavirus (SARS-CoV-2) emerged in Wuhan, China, triggering a pandemic of severe acute respiratory syndrome in humans (COVID-19). Today, the scientific community is investing all the resources available to find any therapy and prevention strategies to defeat COVID-19. In this context, immunonutrition can play a pivotal role in improving immune responses against viral infections. Immunonutrition has been based on the concept that malnutrition impairs immune function. Therefore, immunonutrition involves feeding enriched with various pharmaconutrients (Omega 3 Fatty Acids, Vitamin C, Arginine, Glutamine, Selenium, Zinc, Vitamin, E and Vitamin D) to modulate inflammatory responses, acquired immune response and to improve patient outcomes. In literature, significant evidences indicate that obesity, a malnutrition state, negatively impacts on immune system functionality and on host defense, impairing protection from infections. Immunonutrients can promote patient recovery by inhibiting inflammatory responses and regulating immune function. Immune system dysfunction is considered to increase the risk of viral infections, such as SARS-CoV-2, and was observed in different pathological situations. Obese patients develop severe COVID-19 sequelae, due to the high concentrations of TNF-α, MCP-1 and IL-6 produced in the meantime by visceral and subcutaneous adipose tissue and by innate immunity. Moreover, leptin, released by adipose tissue, helps to increase inflammatory milieu with a dysregulation of the immune response. Additionally, gut microbiota plays a crucial role in the maturation, development and functions of both innate and adaptive immune system, as well as contributing to develop obese phenotype. The gut microbiota has been shown to affect lung health through a vital crosstalk between gut microbiota and lungs, called the “gut-lung axis”. This axis communicates through a bi-directional pathway in which endotoxins, or microbial metabolites, may affect the lung through the blood and when inflammation occurs in the lung, this in turn can affect the gut microbiota. Therefore, the modulation of gut microbiota in obese COVID-19 patients can play a key role in immunonutrition therapeutic strategy. This umbrella review seeks to answer the question of whether a nutritional approach can be used to enhance the immune system’s response to obesity in obese patients affected by COVID-19.
first_indexed 2024-12-13T05:20:06Z
format Article
id doaj.art-cae885bef28e4888bd4b3af8fcc4b3dc
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-12-13T05:20:06Z
publishDate 2020-11-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-cae885bef28e4888bd4b3af8fcc4b3dc2022-12-21T23:58:21ZengBMCJournal of Translational Medicine1479-58762020-11-0118112210.1186/s12967-020-02594-4COVID-19: Is there a role for immunonutrition in obese patient?Laura Di Renzo0Paola Gualtieri1Francesca Pivari2Laura Soldati3Alda Attinà4Claudia Leggeri5Giulia Cinelli6Maria Grazia Tarsitano7Giovanna Caparello8Elena Carrano9Giuseppe Merra10Alberto Maria Pujia11Roberta Danieli12Antonino De Lorenzo13Section of Clinical Nutrition and Nutrigenomic, Department of Biomedicine and Prevention, University of Rome Tor VergataSection of Clinical Nutrition and Nutrigenomic, Department of Biomedicine and Prevention, University of Rome Tor VergataDepartment of Health Sciences, University of MilanDepartment of Health Sciences, University of MilanSchool of Specialization in Food Sciences, University of Rome Tor VergataSchool of Specialization in Food Sciences, University of Rome Tor VergataSchool of Specialization in Food Sciences, University of Rome Tor VergataDepartment of Experimental Medicine, Sapienza University of RomeSchool of Specialization in Food Sciences, University of Rome Tor VergataSchool of Specialization in Food Sciences, University of Rome Tor VergataSection of Clinical Nutrition and Nutrigenomic, Department of Biomedicine and Prevention, University of Rome Tor VergataDepartment of Surgery, University of Tor VergataTelematic University of San Raffaele RomeSection of Clinical Nutrition and Nutrigenomic, Department of Biomedicine and Prevention, University of Rome Tor VergataAbstract On December 12, 2019 a new coronavirus (SARS-CoV-2) emerged in Wuhan, China, triggering a pandemic of severe acute respiratory syndrome in humans (COVID-19). Today, the scientific community is investing all the resources available to find any therapy and prevention strategies to defeat COVID-19. In this context, immunonutrition can play a pivotal role in improving immune responses against viral infections. Immunonutrition has been based on the concept that malnutrition impairs immune function. Therefore, immunonutrition involves feeding enriched with various pharmaconutrients (Omega 3 Fatty Acids, Vitamin C, Arginine, Glutamine, Selenium, Zinc, Vitamin, E and Vitamin D) to modulate inflammatory responses, acquired immune response and to improve patient outcomes. In literature, significant evidences indicate that obesity, a malnutrition state, negatively impacts on immune system functionality and on host defense, impairing protection from infections. Immunonutrients can promote patient recovery by inhibiting inflammatory responses and regulating immune function. Immune system dysfunction is considered to increase the risk of viral infections, such as SARS-CoV-2, and was observed in different pathological situations. Obese patients develop severe COVID-19 sequelae, due to the high concentrations of TNF-α, MCP-1 and IL-6 produced in the meantime by visceral and subcutaneous adipose tissue and by innate immunity. Moreover, leptin, released by adipose tissue, helps to increase inflammatory milieu with a dysregulation of the immune response. Additionally, gut microbiota plays a crucial role in the maturation, development and functions of both innate and adaptive immune system, as well as contributing to develop obese phenotype. The gut microbiota has been shown to affect lung health through a vital crosstalk between gut microbiota and lungs, called the “gut-lung axis”. This axis communicates through a bi-directional pathway in which endotoxins, or microbial metabolites, may affect the lung through the blood and when inflammation occurs in the lung, this in turn can affect the gut microbiota. Therefore, the modulation of gut microbiota in obese COVID-19 patients can play a key role in immunonutrition therapeutic strategy. This umbrella review seeks to answer the question of whether a nutritional approach can be used to enhance the immune system’s response to obesity in obese patients affected by COVID-19.http://link.springer.com/article/10.1186/s12967-020-02594-4COVID-19ImmunonutritionObesityInflammationImmune systemGut microbiota
spellingShingle Laura Di Renzo
Paola Gualtieri
Francesca Pivari
Laura Soldati
Alda Attinà
Claudia Leggeri
Giulia Cinelli
Maria Grazia Tarsitano
Giovanna Caparello
Elena Carrano
Giuseppe Merra
Alberto Maria Pujia
Roberta Danieli
Antonino De Lorenzo
COVID-19: Is there a role for immunonutrition in obese patient?
Journal of Translational Medicine
COVID-19
Immunonutrition
Obesity
Inflammation
Immune system
Gut microbiota
title COVID-19: Is there a role for immunonutrition in obese patient?
title_full COVID-19: Is there a role for immunonutrition in obese patient?
title_fullStr COVID-19: Is there a role for immunonutrition in obese patient?
title_full_unstemmed COVID-19: Is there a role for immunonutrition in obese patient?
title_short COVID-19: Is there a role for immunonutrition in obese patient?
title_sort covid 19 is there a role for immunonutrition in obese patient
topic COVID-19
Immunonutrition
Obesity
Inflammation
Immune system
Gut microbiota
url http://link.springer.com/article/10.1186/s12967-020-02594-4
work_keys_str_mv AT lauradirenzo covid19istherearoleforimmunonutritioninobesepatient
AT paolagualtieri covid19istherearoleforimmunonutritioninobesepatient
AT francescapivari covid19istherearoleforimmunonutritioninobesepatient
AT laurasoldati covid19istherearoleforimmunonutritioninobesepatient
AT aldaattina covid19istherearoleforimmunonutritioninobesepatient
AT claudialeggeri covid19istherearoleforimmunonutritioninobesepatient
AT giuliacinelli covid19istherearoleforimmunonutritioninobesepatient
AT mariagraziatarsitano covid19istherearoleforimmunonutritioninobesepatient
AT giovannacaparello covid19istherearoleforimmunonutritioninobesepatient
AT elenacarrano covid19istherearoleforimmunonutritioninobesepatient
AT giuseppemerra covid19istherearoleforimmunonutritioninobesepatient
AT albertomariapujia covid19istherearoleforimmunonutritioninobesepatient
AT robertadanieli covid19istherearoleforimmunonutritioninobesepatient
AT antoninodelorenzo covid19istherearoleforimmunonutritioninobesepatient